MARKET
IPO

AGDX

Agendia N.V.
AGDX
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
-
Medical Equipment, Supplies & Distribution
2022-09-09
Public Filing
View Prospectus
Pending
Offering
Price Range: Pending
Shares to be Issued: Pending
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: Pending
Listed
No Data
About AGDX
Agendia BV is a Netherlands-based molecular diagnostics company focused solely on breast cancer and tumor research. The Company provides global gene expression profiling services based on DNA microarray technology for physicians and drug developers. The Company provides services based on micro-array genetic profiling technology that allows analyzing of tumor samples and mapping of the tumors specific properties. It also provides prospective gene expression profiles to companies focusing on new drug development in the area of oncology.

Webull offers Agendia N.V. stock information, including NASDAQ: AGDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGDX stock methods without spending real money on the virtual paper trading platform.